EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pyelonephritis Caused by Multidrug-Resistant Bacteria During Pregnancy: A Case–Control Study

Gabriel-Ioan Anton, Maria Caliniuc, Carina-Alexandra Bandac, Demetra Gabriela Socolov iD, Ingrid Andrada Tănasa, Rodica Radu iD, Radu-Stefan Miftode iD, Theodor Florin Pantilimonescu iD, Vlad Ichim, Egidia Gabriela Miftode, Ionela-Larisa Miftode iD, Viorel Dragoș Radu iD

Antibiotics · 10.02.2026 · 15 (2) · 194

DOI: 10.3390/antibiotics15020194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 10.02.2026. Verfasst von Gabriel-Ioan Anton und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pyelonephritis during pregnancy represents a significant maternal–fetal risk, particularly in the context of increasing multidrug-resistant (MDR) bacterial infections. This study aimed to characterize the microbiological profiles and antimicrobial resistance patterns of MDR pathogens causing pyelonephritis in pregnancy. Secondary objectives included the evaluation of patient characteristics, associated risk factors, and pregnancy outcomes.

Methods

A retrospective comparative study was conducted including 171 pregnant patients hospitalized with acute pyelonephritis between 1 January 2017 and 30 April 2025. Thirty-four patients with MDR bacterial infections were compared with 137 patients with infections caused by pathogens with conserved antibiotic susceptibility (Non-MDR).

Results

Patients with MDR pyelonephritis were significantly older than those with Non-MDR infections (mean age 27.76 vs. 25.30 years, p = 0.03). MDR infections were more frequently diagnosed in the third trimester of pregnancy (58.8% vs. 29.9%, p = 0.003) and affected multiparous women more often (44.1% vs. 19.7%, p = 0.006). No statistically significant differences were observed between groups regarding clinical presentation or laboratory parameters (p > 0.05). Prior antibiotic exposure was significantly more common in the MDR group (85.29% vs. 26.61%, p < 0.001), as was a history of urological procedures, including urinary catheterization (29.41% vs. 15.10%, p = 0.009). For multivariate analysis, two factors were predictive for pyelonephritis with MDR pathogens: previous antibiotic treatment—OR 20.37 (95% CI 2.19–189.88) and urological procedures—OR 13.23 (95% CI 2.24-78-22). Escherichia coli was the predominant pathogen in both groups but was isolated more frequently in the Non-MDR cohort (81.75% vs. 58.82%, p = 0.015), followed by Klebsiella pneumoniae, which appeared more frequently in the study group (23.53% vs. 10.22%, p = 0.011). MDR isolates demonstrated significantly higher resistance rates to all tested antibiotics (p < 0.05). Complete resistance to ampicillin was observed in the MDR group (100%), compared with 58.01% in the Non-MDR group, indicating markedly reduced efficacy of this agent. Adverse neonatal outcomes were more frequent in the MDR group, with higher rates of Apgar scores < 7 at admission (23.5% vs. 8.8%, p = 0.01) and increased neonatal intensive care unit admission (20.6% vs. 7.3%, p = 0.02). For multivariate analysis, pyelonephritis with MDR pathogens was predictive for Neonatal Intensive Care Unit (NICU) admission (OR 8.17, 95% CI 2.41–27.67).

Conclusions

These findings highlight the need for the periodic revision of empirical antibiotic protocols and risk-adapted therapeutic strategies in pregnant patients in order to reduce maternal and fetal morbidity.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancemultidrug-resistant bacteriapregnancypyelonephritis

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Department of Urology, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Department of Urology, "Dr. C.I. Parhon" University Hospital, 700503 Iasi, Romania.
  • Department of Internal Medicine, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Department of Infectious Diseases, Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Saint Parascheva Clinical Hospital of Infectious Diseases, 700116 Iasi, Romania.

ORCID-Profile: Demetra Gabriela Socolov, Rodica Radu, Radu-Stefan Miftode, Theodor Florin Pantilimonescu, Ionela-Larisa Miftode, Viorel Dragoș Radu

Zitieren

APA

Anton, G. I., Caliniuc, M., Bandac, C. A., Socolov, D. G., Tănasa, I. A., Radu, R., Miftode, R. S., Pantilimonescu, T. F., Ichim, V., Miftode, E. G., Miftode, I. L., & Radu, V. D. (2026). Pyelonephritis Caused by Multidrug-Resistant Bacteria During Pregnancy: A Case–Control Study. Antibiotics, 15(2), 194. https://doi.org/10.3390/antibiotics15020194

Vancouver

Anton GI, Caliniuc M, Bandac CA, Socolov DG, Tănasa IA, Radu R, et al. Pyelonephritis Caused by Multidrug-Resistant Bacteria During Pregnancy: A Case–Control Study. Antibiotics. 2026;15(2):194. doi:10.3390/antibiotics15020194

BibTeX
@article{Anton2026,
  author = {Anton, Gabriel-Ioan and Caliniuc, Maria and Bandac, Carina-Alexandra and Socolov, Demetra Gabriela and Tănasa, Ingrid Andrada and Radu, Rodica and Miftode, Radu-Stefan and Pantilimonescu, Theodor Florin and Ichim, Vlad and Miftode, Egidia Gabriela and Miftode, Ionela-Larisa and Radu, Viorel Dragoș},
  title = {Pyelonephritis Caused by Multidrug-Resistant Bacteria During Pregnancy: A Case–Control Study},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {194},
  doi = {10.3390/antibiotics15020194}
}
Kostenlos starten →